Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Venus Remedies Limited
VENUSREM | NSE
861.05
INR41.00
5.00%
VENUSREM | NSE
Loading StockChartView...
About Venus Remedies Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
861.05
Open
859.00
High
861.05
Low
832.05
Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas such as analgesic analgesic and antipyretic anti-diabetic antibiotic anticoagulant cardiac disinfectant and antiseptic gastro therapy hand sanitizers hormones iron supplements neurology oncology pain management respiratory skin and wound care stress reliever urology and vitamins/minerals/nutrients as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula India.
View LessVENUSREM | NSE
Risk
70.4
Sharpe
3.58
Luna's Score
66/100
Recommendation
Buy
Luna says (VENUSREM | NSE)
What's Working
Positive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
63.4%1 month
70.4%3 months
56.8%6 months
58.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
16.58
Fwd. PE
-
Price to book
0.97
Debt to equity
0.08
Debt to assets
0.07
Ent. to EBITDA
6.07
Ent. to rev.
0.73
PEG
-
Other Fundamentals
EBITDA
614.93M
MarketCap
11.51B
MarketCap(USD)
123.51M
Div. yield
-
Op. margin
4.86
Erngs. growth
4.50
Rev. growth
14.10
Ret. on equity
6.01
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
117.80
Range1M
322.65
Range3M
322.65
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.30
Price X volume
14.76M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 6.07 | 24.85 | Cheaper |
| Ent. to Revenue | 0.73 | 11.40 | Cheaper |
| PE Ratio | 16.58 | 51.36 | Cheaper |
| Price to Book | 0.97 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 56.78 | 42.17 | Riskier |
| Debt to Equity | 0.08 | 0.35 | Cheaper |
| Debt to Assets | 0.07 | 0.17 | Cheaper |
| Market Cap | 11.51B | 290.82B | Emerging |
